Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of an "A" design with a darker arch and a lighter horizontal swoop curving up and to the right.
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
284 x 299
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
LEO Pharma A/S
*MAILING ADDRESS
Industriparken 55
*CITY
Ballerup
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Denmark
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
2750
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
public limited company (plc)
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED
Denmark
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical and medical preparations for treatment of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and for
treatment of the skin.
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
038
*IDENTIFICATION
Providing online forums for information and communication about skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in
relation to treatment of the skin.
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Scientific and medical research in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to
treatment of the skin; research and development services and scientific research and testing of pharmaceuticals, all in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory
diseases and in relation to treatment of the skin; providing information and consulting services in the field of scientific research and development services and scientific research in relation to
skin diseases and treatment of the skin; testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the
skin.
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
044
*IDENTIFICATION
Medical testing for diagnostic or treatment purposes, in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases
and in relation to treatment of the skin; medical services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical,
health and pharmaceutical consultation services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin.
all the other attorneys of Finnegan, Henderson, Farabow, Garrett & Dunner LLP
CORRESPONDENCE INFORMATION
NAME
B. Brett Heavner
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
docketing@finnegan.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
travis.smith@finnegan.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
4
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
1400
*TOTAL FEES PAID
1400
SIGNATURE INFORMATION
SIGNATURE
/Tom Friis-Mikkelsen/
SIGNATORY'S NAME
Tom Friis-Mikkelsen
SIGNATORY'S POSITION
Senior Manager, Head of Trademarks, Designs and Domain Names
DATE SIGNED
11/23/2021
SIGNATURE METHOD
Sent to third party for signature
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97139262
Filing Date:11/23/2021
To the Commissioner for Trademarks:
MARK: (Stylized and/or Design, see mark) The applicant is not claiming color as a feature of the mark. The mark consists of an "A"
design with a darker arch and a lighter horizontal swoop curving up and to the right.
The applicant, LEO Pharma A/S, a public limited company (plc) legally organized under the laws of Denmark, having an address of
Industriparken 55
Ballerup 2750
Denmark
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical and medical preparations for treatment of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and for treatment of the skin.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 038: Providing online forums for information and communication about skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of
the skin.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: Scientific and medical research in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin;
research and development services and scientific research and testing of pharmaceuticals, all in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to
treatment of the skin; providing information and consulting services in the field of scientific research and development services and scientific research in relation to skin diseases and treatment of
the skin; testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 044: Medical testing for diagnostic or treatment purposes, in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to
treatment of the skin; medical services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical, health and
pharmaceutical consultation services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: B. Brett Heavner. Other appointed attorneys are all the other attorneys of Finnegan, Henderson, Farabow, Garrett & Dunner LLP. B. Brett
Heavner of Finnegan, Henderson, Farabow, Garrett & Dunner LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
901 New York Avenue NW
Washington, District of Columbia 20001
United States
202-408-4000(phone)
202-408-4400(fax)
docketing@finnegan.com
The docket/reference number is 14894.0074.
B. Brett Heavner submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1400 has been submitted with the application, representing payment for 4 class(es).
Declaration
Declaration Signature
Signature: /Tom Friis-Mikkelsen/ Date: 11/23/2021
Signatory's Name: Tom Friis-Mikkelsen
Signatory's Position: Senior Manager, Head of Trademarks, Designs and Domain Names
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 97139262
Payment Accounting Date: 11/23/2021
Serial Number: 97139262
Internet Transmission Date: Tue Nov 23 12:10:03 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.X.X-2021112312100349690
5-97139262-781bf3dd8864c8b75432d414617b8
279d621414e2e6a7a9b5a44b39f72e732f-CC-10
012841-20211118221137695408